Holding, Stress, and Bonding During Therapeutic Hypothermia
Public ClinicalTrials.gov record NCT03079284. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
The Effects of Holding on Stress and Bonding in Mother-Infant Dyads During Therapeutic Hypothermia
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Ten infants undergoing therapeutic hypothermia for hypoxic-ischemic encephalopathy will be enrolled in a new protocol that will allow mothers to hold their infants during the hypothermia treatment period. This is a safety study that will assess whether or not there is an increase in adverse event frequency in infants that are held during hypothermia. Parents and NICU nurses will be given a questionnaire after holding is complete investigating their feelings on maternal-infant bonding and safety of the holding protocol.
Study identification
- NCT ID
- NCT03079284
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 10 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 24 Hours to 3 Days
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 19, 2017
- Primary completion
- Sep 22, 2017
- Completion
- Sep 22, 2017
- Last update posted
- Sep 3, 2025
2017
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Maine Medical Center | Portland | Maine | 04102 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Hypoxic-Ischemic Encephalopathy trials
Other public records listing Hypoxic-Ischemic Encephalopathy. Sorted by last update posted; newest first. Not a recommendation.
- NCT07628829: Neonatal Neurological Observation With Video AI Recruiting
- NCT05610085: A Dose Escalation Study of Levetiracetam in the Treatment of Neonatal Seizures Recruiting
- NCT05971446: Healthy Little Eyes Recruiting
- NCT06195345: Individual Cerebral Hemodynamic Oxygenation Relationships (ICHOR 1) Recruiting
- NCT05778188: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of RLS-0071 in Newborns With Moderate or Severe Hypoxic-Ischemic Encephalopathy Undergoing Therapeutic Hypothermia Recruiting
- NCT06448780: Dose Optimization of Caffeine for HIE Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03079284, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 3, 2025 · Synced Sep 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03079284 live on ClinicalTrials.gov.